ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Clinical trials for ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD) explained in plain language.
Never miss a new study
Get alerted when new ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD) trials appear
Sign up with your email to follow new studies for ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common ADHD drug also treat depression?
Disease control Recruiting nowThis Phase 2 trial tests whether dexamfetamine, a stimulant used for ADHD, can safely and effectively treat both ADHD and moderate to severe depression in adults. 105 participants will receive either a fast-acting or long-acting version of the drug, or a placebo. The study is cur…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: PHASE2 • Sponsor: Prof. Dr. Frank Behrens • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New ADHD pill tested for Year-Long safety in kids
Disease control Recruiting nowThis study tests the safety of an experimental drug called EB-1020, taken once daily, in 180 children and adolescents with ADHD over 52 weeks. Researchers will monitor side effects and how well participants tolerate the medication. The trial is open to those who completed a prior…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New daily pill for kids with ADHD enters key trial
Disease control Recruiting nowThis study tests a new medication called EB-1020 for children and teenagers with ADHD. It is a once-daily capsule that aims to reduce symptoms like inattention and hyperactivity. The trial involves 315 participants in Japan and China, comparing two doses of the drug against a pla…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: PHASE2, PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a phone app curb risky drinking in young adults with ADHD?
Symptom relief Recruiting nowThis study tests whether a smartphone-based program is practical and helpful for young adults aged 18-25 who have ADHD and drink heavily. Participants use the app for 31 days to improve awareness and self-control around alcohol. The goal is to see if the app reduces binge drinkin…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: NA • Sponsor: Traci Kennedy • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a cannabis compound help teens with ADHD?
Symptom relief Recruiting nowThis study tests whether a cannabis compound called cannabigerol (CBG) can reduce ADHD symptoms like inattention and hyperactivity in teenagers. Sixty adolescents aged 12 to 17 who have not responded well to other treatments will receive either CBG oil or a placebo for 12 weeks. …
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: PHASE1, PHASE2 • Sponsor: Universidade do Sul de Santa Catarina • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could magnetic pulses help kids with ADHD?
Symptom relief Recruiting nowThis study tests whether a non-invasive brain stimulation technique called theta burst rTMS can reduce ADHD symptoms in children aged 9 to 15. Thirty participants with an ADHD diagnosis will receive the treatment, and researchers will measure attention and symptom severity. The g…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Video games as medicine? new study tests brain training for ADHD kids at home
Symptom relief Recruiting nowThis study is testing whether playing special brain-controlled games at home can help school-aged children (ages 7 to 11) with mild to moderate ADHD pay better attention and feel less hyperactive. About 146 children will play these neurofeedback games over several weeks, and rese…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could ritalin help kids with sickle cell disease? new pilot trial launches
Symptom relief Recruiting nowThis pilot study at St. Jude Children's Research Hospital is testing whether a daily dose of extended-release methylphenidate (Ritalin) can safely improve attention, thinking, and school performance in children aged 8 to 17 with sickle cell disease. The trial will enroll 72 parti…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Brain scans reveal how ADHD meds work in kids with autism
Symptom relief Recruiting nowThis study looks at whether Adderall XR can reduce ADHD symptoms in children and teens (ages 8-18) who also have autism. Participants will take the medication or a placebo for 4 weeks and complete brain scans to measure changes in attention, impulsivity, and memory. The goal is t…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: PHASE4 • Sponsor: Gagan Joshi • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
VR training aims to curb distracted driving in teens with ADHD
Symptom relief Recruiting nowThis study tests a computer-based training program called FOCAL+ for teens with ADHD aged 16-19 who have a driver's license. The training teaches them to limit how long they look away from the road while driving. Researchers will measure if the training reduces risky glances duri…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can tea compounds sharpen focus in ADHD and autism? new study seeks answers
Symptom relief Recruiting nowThis pilot study tests whether a combination of two natural compounds, L-theanine and paraxanthine, can temporarily improve attention and self-control in adults with ADHD or autism. About 24 participants will complete thinking tests and brain scans after taking the supplement or …
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: NA • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Wearable tech unlocks ADHD secrets: sleep and activity patterns may explain symptoms
Knowledge-focused Recruiting nowThis study looks at how sleep, physical activity, and daily rhythms relate to ADHD symptoms and brain function in 200 children. Kids wear a wristband for two weeks and complete cognitive tests and MRI scans. The goal is to better understand why ADHD affects people differently and…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Can your Child's DNA predict the best ADHD drug?
Knowledge-focused Recruiting nowThis study explores whether a child's genetic makeup influences how well they respond to the ADHD medication methylphenidate. Researchers will track symptom changes and side effects in 400 participants aged 6-24 across Western Canada. The goal is to find genetic markers that coul…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Walking clues to ADHD? new study uses footprints to spot disorder
Knowledge-focused Recruiting nowThis study looks at whether how a child stands and walks can help predict ADHD. Researchers will measure foot pressure and posture in 100 middle school students, half with ADHD symptoms and half without. They will use machine learning to see if these physical measurements can acc…
Matched conditions: ATTENTION DEFICIT/HYPERACTIVITY DISORDER(ADHD)
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:29 UTC